Development and validation of a polycystic liver disease-complaint-specific-assessment (POLCA)

Polycystic liver disease (PCLD) may lead to extensive hepatomegaly and invalidating complaints. Therapeutic decisions, including somatostatin-analogues (SA), (non)-transplant surgery are besides the existence of hepatomegaly, also guided by the severity of complaints. We developed and validated a self-report instrument to capture the presence and severity of disease specific complaints for PCLD.publisher: Elsevier articletitle: Development and validation of a polycystic liver disease complaint-specific assessment (POLCA) journaltitle: Journal of Hepatology articlelink: http://dx.doi.org/10.1016/j.jhep.2014.06.024 content_type: article copyright: Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.status: publishe